XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022 3,331,201 518,140        
Balance at Dec. 31, 2022 $ 24,287,211 $ 518 $ 18,983,339 $ 0 $ (52,268,916) $ (33,285,059)
Conversion of convertible preferred stock to common stock (in shares) (3,331,201) 2,936,566        
Conversion of convertible preferred stock to common stock $ (24,287,211) $ 2,937 24,284,274 0 0 24,287,211
Issuance of common stock upon settlement of convertible notes (in shares) 0 795,905        
Issuance of common stock upon settlement of convertible notes $ 0 $ 796 6,988,953 0 0 6,989,749
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs (in shares) 0 1,360,244        
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs $ 0 $ 1,360 10,337,754 0 0 10,339,114
Sale of common stock (in shares) 0 63,422        
Sale of common stock $ 0 $ 63 809,937 0 0 810,000
Stock-based compensation expense, including vesting of RSUs $ 0 $ 0 407,632 0 0 407,632
Stock-based compensation expense, including vesting of RSUs (in shares)   77        
Issuance of common stock from exercises of stock options (in shares) 0 359        
Issuance of common stock from exercises of stock options $ 0 $ 0 0 0 0 0
Repurchase of common stock from net settled stock option (in shares) 0 (193)        
Repurchase of common stock from net settled stock option $ 0 $ 0 0 0 0 0
Net loss $ 0 $ 0 0 0 (2,171,873) (2,171,873)
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs (in shares) 0 63,422        
Net unrealized gain on marketable securities           0
Balance (in shares) at Dec. 31, 2023 0 5,674,520        
Balance at Dec. 31, 2023 $ 0 $ 5,674 61,811,889 0 (54,440,789) 7,376,774
Sale of common stock (in shares)   2,083,262        
Sale of common stock   $ 2,083 46,396,523 0 0 46,398,606
Stock-based compensation expense, including vesting of RSUs 0 0 1,405,722 0 0 1,405,722
Net loss 0 $ 0 0 0 (16,290,695) (16,290,695)
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs (in shares)   2,083,262        
Stock options granted in lieu of compensation $ 0 $ 0 255,724 0 0 255,724
Cashless exercise of prefunded warrants (in shares) 0 944,937        
Cashless exercise of prefunded warrants $ 0 $ 945 (945) 0 0 0
Net unrealized gain on marketable securities   $ 0 0 56,197 0 56,197
Balance (in shares) at Dec. 31, 2024 0 8,702,719        
Balance at Dec. 31, 2024 $ 0 $ 8,702 $ 109,868,913 $ 56,197 $ (70,731,484) $ 39,202,328